Dr. David Dougherty, M.D.
Infectious Disease (Infectious Disease Physician)
1720 Nicholasville Rd Ste 602
Lexington, KY 40503
Who else practices at this address →
Fayette County includes mental health (15% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of Louisville School of Medicine (2013)
- Years since graduation
- 13
- In the NPI registry since
- 2013
- Medicare patients seen, 2024
- 268
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2013Medical school: University of Louisville School of Medicine
- 2013Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
KY license 50868 · TN license 55687 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baptist Health Lexington Lexington, KY
- Saint Joseph East Lexington, KY
- Saint Joseph Hospital Lexington, KY
- Baptist Health Richmond Richmond, KY
Medical groups
- Lexington Infectious Disease Consultants Psc (12 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 268
- Services billed
- 49,461
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, daptomycin, 1 mg | 29,700 | 28 |
| Injection, ceftriaxone sodium, per 250 mg | 808 | 39 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 707 | 166 |
| Established patient office or other outpatient visit, 30-39 minutes | 276 | 100 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 245 | 86 |
| Injection, ertapenem sodium, 500 mg | 184 | 30 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 140 | 126 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 122 | 50 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 74 | 22 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 52 | 46 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Doxycycline Monohydrate Other prescribers in Lexington, KY | 83 |
| Cephalexin Other prescribers in Lexington, KY | 76 |
| Daptomycin | 68 |
| Amoxicillin-Clavulanate Potass (amoxicillin/potassium clav) Other prescribers in Lexington, KY | 41 |
| Ertapenem (ertapenem sodium) | 41 |
| Vancomycin Hcl | 36 |
| Ceftriaxone (ceftriaxone sodium) Other prescribers in Lexington, KY | 32 |
| Methenamine Hippurate Other prescribers in Lexington, KY | 30 |
| Epinephrine Other prescribers in Lexington, KY | 29 |
| Odefsey (emtricitab/rilpiviri/tenof ala) | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 14 companies reported 111 payments worth $35,560 in total to this clinician.
| Gilead Sciences, Inc. | $34,069 |
|---|---|
| Viiv Healthcare Company | $285 |
| Shionogi Inc | $248 |
| Insmed, Inc. | $233 |
| La Jolla Pharmaceutical Company | $191 |
| Astellas Pharma US Inc | $109 |
| Melinta Therapeutics, LLC | $102 |
| Aimmune Therapeutics, Inc. | $88.81 |
| Compensation for services other than consulting (speaking, faculty) | $26,740 |
|---|---|
| Travel and Lodging | $5,840 |
| Food and Beverage | $2,980 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. Apr 21, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4027928;GTF;12217820 | $4,210 |
| Gilead Sciences, Inc. May 9, 2025 | Compensation for services other than consulting (speaking, faculty) Descovy · HIV Company’s description;4028182;GTF;12217820 | $4,210 |
| Gilead Sciences, Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4259010;AHM;12217820 | $3,360 |
| Gilead Sciences, Inc. Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4114914;AHM;12217820 | $2,570 |
| Gilead Sciences, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4181758;AHM;12217820 | $2,570 |
| Gilead Sciences, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4124860;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4112439;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4262028;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4261886;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Oct 23, 2025 | Travel and Lodging Yeztugo · HIV · travel to Pittsburgh, PA · in-kind Company’s description;4327984;AHM;12217820 | $891 |
All 24 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Gilead Sciences, Inc. Nov 21, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4286316;GTF;12217820 | $400 |
| Gilead Sciences, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4261886;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Nov 6, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4285853;GTF;12217820 | $500 |
| Gilead Sciences, Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4259010;AHM;12217820 | $3,360 |
| Gilead Sciences, Inc. Oct 23, 2025 | Travel and Lodging Yeztugo · HIV · travel to Pittsburgh, PA · in-kind Company’s description;4327984;AHM;12217820 | $891 |
| Gilead Sciences, Inc. Oct 21, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4262028;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Oct 21, 2025 | Travel and Lodging Yeztugo · HIV · travel to Pittsburgh, PA · in-kind Company’s description;4258811;AHM;12217820 | $284 |
| Gilead Sciences, Inc. Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4285682;GTF;12217820 | $400 |
| Gilead Sciences, Inc. Oct 14, 2025 | Travel and Lodging Yeztugo · HIV · travel to Pittsburgh, PA · in-kind Company’s description;4258956;AHM;12217820 | $808 |
| Gilead Sciences, Inc. Aug 29, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4181758;AHM;12217820 | $2,570 |
| Gilead Sciences, Inc. Aug 26, 2025 | Travel and Lodging Yeztugo · HIV · travel to Dayton, OH · in-kind Company’s description;4327583;AHM;12217820 | $835 |
| Gilead Sciences, Inc. Jul 24, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4112439;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. Jul 21, 2025 | Travel and Lodging Yeztugo · HIV · travel to Cincinnati, OH · in-kind Company’s description;4327602;AHM;12217820 | $784 |
| Gilead Sciences, Inc. Jul 15, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4114914;AHM;12217820 | $2,570 |
| Gilead Sciences, Inc. Jul 7, 2025 | Compensation for services other than consulting (speaking, faculty) Yeztugo · HIV Company’s description;4083898;GTF;12217820 | $600 |
| Gilead Sciences, Inc. Jun 6, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4124860;AHM;12217820 | $1,980 |
| Gilead Sciences, Inc. May 9, 2025 | Compensation for services other than consulting (speaking, faculty) Descovy · HIV Company’s description;4028182;GTF;12217820 | $4,210 |
| Gilead Sciences, Inc. Apr 21, 2025 | Compensation for services other than consulting (speaking, faculty) Biktarvy · HIV Company’s description;4027928;GTF;12217820 | $4,210 |
| Gilead Sciences, Inc. Apr 4, 2025 | Travel and Lodging Biktarvy · HIV · travel to Dallas, TX · in-kind Company’s description;4027627;GTF;12217820 | $330 |
| Gilead Sciences, Inc. Apr 4, 2025 | Travel and Lodging Biktarvy · HIV · travel to Dallas, TX · in-kind Company’s description;4027548;GTF;12217820 | $39.91 |
| Gilead Sciences, Inc. Apr 3, 2025 | Travel and Lodging Descovy · HIV · travel to Dallas, TX · in-kind Company’s description;4028135;GTF;12217820 | $330 |
| Gilead Sciences, Inc. Apr 2, 2025 | Travel and Lodging Biktarvy · HIV · travel to Dallas, TX · in-kind Company’s description;4027585;GTF;12217820 | $615 |
| Gilead Sciences, Inc. Apr 2, 2025 | Travel and Lodging Descovy · HIV · travel to Dallas, TX · in-kind Company’s description;4028245;GTF;12217820 | $615 |
| Gilead Sciences, Inc. Apr 2, 2025 | Travel and Lodging Descovy · HIV · travel to Dallas, TX · in-kind Company’s description;4028075;GTF;12217820 | $306 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $27,595 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Tra…
Gilead Sciences, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.